RIPK1 and neoplasm: Our findings suggest that targeting proteins involved in RIPK1 pro-survival checkpoints and promoting direct RIPK1 activation is a viable mechanism to potentiate TNF-induced cell death and enhance the impact of immune cell-mediated tumor clearance.